ConvaTec Group CTEC.L · GBp

Its shares trade on LSE under the ticker CTEC.L. It has been listed since 26 October 2016. It is a member of the FTSE 100. In the fiscal year to 31 December 2025, it reported revenue of $2.49bn and net income of $178.7m. At that date it held total assets of $3.78bn and shareholders' equity of $1.52bn.

ConvaTec Group Plc operates as holding company, which engages in medical business. The company is headquartered in Reading, Berkshire. The company went IPO on 2016-10-26. The firm focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions. The company operates across market franchises, such as Advanced Wound Care, which provides advanced wound dressings and skin care products; Ostomy Care, which provides devices, accessories and services for people with a stoma, resulting from colorectal cancer, inflammatory bowel disease, bladder cancer, obesity and other causes; Continence and Critical Care, which provides products for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida and other causes, and Infusion Devices, which provide disposable infusion sets.

Figures and description from our data supplier, not checked against the company's own report.

• Dr. John McadamNon-Executive Independent Chairman of the Board£376,000
• Mr. Jonny MasonInterim Chief Executive Officer, Executive Director, since 2022£2.8m
• Ms. Fiona RyderInterim Chief Financial Officer
• Ms. Anne BelcherPresident and Chief Operating Officer - Global Emerging Markets
• Ms. Kjersti GrimsrudPresident and Chief Operating Officer - Infusion Care
• Mr. Mark JasseyPresident and Chief Operating Officer - Continence Care and Home Services Group
• Mr. Bruno PinheiroPresident and Chief Operating Officer - Ostomy Care
• Mr. David ShepherdaPresident and Chief Operating Officer - Advanced Wound Care
• Mr. John HallerExecutive Vice President, Chief Quality and Operations Officer
• Ms. Emma RoseiChief Human Resources Officer, Executive Vice President
• Dr. Divakar RamakrishnanExecutive Vice President, Chief Technology Officer and Head - Research and Development
• Mr. James KertonExecutive Vice President, General Counsel, Company Secretary

Overall

74

Environment

61

Social

99

Governance

63

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.